CRNT
Overvalued by 172.8% based on the discounted cash flow analysis.
Market cap | $244.30 Million |
---|---|
Enterprise Value | $246.01 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.05 |
Beta | 0.85 |
Outstanding Shares | 85,418,321 |
Avg 30 Day Volume | 517,433 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 52.48 |
---|---|
PEG | -65.99 |
Price to Sales | 0.71 |
Price to Book Ratio | 2.83 |
Enterprise Value to Revenue | 0.7 |
Enterprise Value to EBIT | 10 |
Enterprise Value to Net Income | 52 |
Total Debt to Enterprise | 0.12 |
Debt to Equity | 0.23 |
No data
No data